✦ LIBER ✦

Combining phase I and phase II in a potential reduction algorithm for linear programming

✍ Scribed by Michael J. Todd

Publisher: Springer-Verlag
Year: 1993
Tongue: English
Weight: 989 KB
Volume: 59
Category: Article
ISSN: 0025-5610
DOI: 10.1007/bf01581241

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A combined phase I—phase II scaled poten

A combined phase I—phase II scaled potential algorithm for linear programming

✍ Kurt M. Anstreicher 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 550 KB

A combined phase I-phase II projective a

A combined phase I-phase II projective algorithm for linear programming

✍ Kurt M. Anstreicher 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 669 KB

On Anstreicher's combined phase I—phase

On Anstreicher's combined phase I—phase II projective algorithm for linear programming

✍ Michael J. Todd 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 677 KB

On partial updating in a potential reduc

On partial updating in a potential reduction linear programming algorithm of Kojima, Mizuno, and Yoshise

✍ Robert A. Bosch; Kurt M. Anstreicher 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 785 KB

A phase I/II study of combined cisplatin

A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy

✍ Daniel M. Green; Gary V. Burton; Edwin B. Cox; Dean Hanson; Joseph Moore; James 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Phase I/II study of a combined gemcitabi

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma

✍ Tetsuro Tsukamoto; Junji Yonese; Yuhei Ohkubo; Iwao Fukui 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat